The biology of VEGF and its receptors, Nat Med, vol.9, pp.669-676, 2003. ,
Vascular endothelial growth factor: basic science and clinical progress, Endocr Rev, vol.25, pp.581-611, 2004. ,
Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy, Int J Mol Sci, vol.18, p.383, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02337324
The sVEGFR1-i13 splice variant regulates a beta1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma, Br J Cancer, vol.118, pp.1596-1608, 2018. ,
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancer, PLoS One, vol.7, p.38231, 2012. ,
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer, Oncologist, vol.15, pp.577-583, 2010. ,
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study, J Clin Oncol, vol.27, pp.3020-3026, 2009. ,
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use, J Cell Mol Med, vol.14, pp.528-552, 2010. ,
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor, Proc Natl Acad Sci, vol.90, pp.10705-10709, 1993. ,
Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression, Cancer, vol.79, pp.206-213, 1997. ,
Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR, Biochem Biophys Res Commun, vol.226, pp.324-328, 1996. ,
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate, Proc Natl Acad Sci, vol.95, pp.8795-8800, 1998. ,
Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin, J Cell Sci, vol.116, pp.3479-3489, 2003. ,
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin, Blood, vol.111, pp.3479-3488, 2008. ,
Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis, Vasc Cell, vol.3, p.15, 2011. ,
VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing, FEBS Lett, vol.587, pp.2179-2185, 2013. ,
Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1, Proc Natl Acad Sci, vol.108, pp.3276-3281, 2011. ,
NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth, Cancer Discov, vol.5, pp.182-197, 2015. ,
VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a beta1 integrin/VEGFR autocrine loop, Epub Ahead of Print, 2018. ,
VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2, Oncogene, vol.34, pp.3107-3119, 2015. ,
Genetic alteration profiling of patients with resected squamous cell lung carcinomas, Oncotarget, pp.36590-36601, 2016. ,
The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2, Genes Dev, vol.28, pp.1929-1939, 2014. ,
The SR protein family of splicing factors: master regulators of gene expression, Biochem J, vol.417, pp.15-27, 2009. ,
Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma, PLoS One, vol.7, p.46539, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02337424
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung, Cancer Res, vol.66, pp.7466-7472, 2006. ,
Ground rules of the pluripotency gene regulatory network, Nat Rev Genet, vol.18, pp.180-191, 2017. ,
Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosis, Cancer Sci, vol.98, pp.405-410, 2007. ,
Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer, Int J Cancer, vol.98, pp.14-18, 2002. ,
, Scientific RepoRts |, vol.9, 2019.
Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A, Clin Cancer Res, vol.9, pp.1399-1405, 2003. ,
Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types, Clin Biochem, vol.37, pp.840-845, 2004. ,
A phase II and biomarker study of ramucirumab, a human monoclonal antibody targeting the VEGF receptor-2, as first-line monotherapy in patients with advanced hepatocellular cancer, Clin Cancer Res, vol.19, pp.6614-6623, 2013. ,
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients, Proc Natl Acad Sci, vol.112, pp.14325-14330, 2015. ,
Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy, Clin Cancer Res, vol.7, 1992. ,
Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer, Proc Natl Acad Sci, vol.112, pp.1547-1552, 2015. ,
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance, J Clin Oncol, vol.28, pp.453-459, 2010. ,
A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia, J Clin Endocrinol Metab, vol.94, pp.2524-2530, 2009. ,
Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production, Biol Reprod, vol.94, p.59, 2016. ,
The Soluble VEGF Receptor sFlt-1 Contributes to Impaired Neovascularization in Aged Mice, Aging Dis, vol.8, pp.287-300, 2017. ,
Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells, Cell Stem Cell, vol.15, pp.92-101, 2014. ,
Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype, EMBO Mol Med, vol.6, pp.539-550, 2014. ,
E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35, Cell Death Differ, vol.15, pp.1815-1823, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00360967
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma, J Thorac Oncol, vol.6, pp.244-285, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-00561753
E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short), Cell Death Differ, vol.13, pp.260-272, 2006. ,
URL : https://hal.archives-ouvertes.fr/inserm-00172959